HZSY(600191)
Search documents
华资实业:华资实业董事会薪酬与考核委员会实施细则(2023年8月修订)
2023-08-29 09:12
8694997edaad480e9a31e04eb78e11c1 董事会薪酬与考核委员会实施细则 2023 年 8 月 8694997edaad480e9a31e04eb78e11c1 目 录 | 第一章 | 总则………………………………………………………………2 | | --- | --- | | 第二章 | 人员组成 …………………………………………………………2 | | 第三章 | 职责权限 …………………………………………………………3 | | 第四章 | 决策程序 …………………………………………………………3 | | 第五章 | 议事规则 …………………………………………………………4 | | 第六章 | 附 则 ……………………………………………………………5 | 1 8694997edaad480e9a31e04eb78e11c1 第一章 总则 第一条 为进一步建立健全公司董事(非独立董事)及高级管理人员的 考核和薪酬管理制度,完善公司治理结构,根据《中华人民共和国公司法》、 《上市公司治理准则》、《公司章程》及其他有关规定,公司特设立董事会 薪酬与考核委员会,并制定本实施细则。 第二条 薪酬 ...
华资实业:华资实业董事会议事规则(2023年8月修订)
2023-08-29 09:12
董事会议事规则 2023 年 8 月 | | | | 第一章 总则 2 | | --- | | 第二章 董事会及其职权 2 | | 第三章 董事会的召开 4 | | 第四章 董事会会议的表决和决议 5 | | 第五章 董事会专门委员会 6 | | 第六章 附则 8 | 第一章 总则 第一条 为进一步完善包头华资实业股份有限公司(以下简称"公司")法 人治理结构,确保公司董事会的工作效率和科学决策,保证董事会依法行使职权, 维护公司和全体股东的合法权益,根据《公司法》、《证券法》、《上市公司章程指 引》、《上海证券交易所股票上市规则》、《上海证券交易所上市公司自律监管指引 第 1 号——规范运作》、公司章程以及其他有关法律、法规及规范性文件的规定, 特制定本议事规则。 第二章 董事会及其职权 第二条 公司设董事会,对股东大会负责。 董事会遵照《公司法》、公司章程及其他有关法律、法规及规范性文件的规 定,履行职责。 第三条 董事会由 9 名董事组成,设董事长 1 人,副董事长 1 人,独立董事 3 人,暂不设职工代表董事。 第四条 董事会行使下列职权: 2 (一)召集股东大会,并向股东大会报告工作; (二)执行股 ...
华资实业:华资实业董事会审计委员会实施细则(2023年8月修订)
2023-08-29 09:12
9966c0085b1f4a9aa461d7ee6fd3b115.doc 董事会审计委员会实施细则 2023 年 8 月 1 9966c0085b1f4a9aa461d7ee6fd3b115.doc | | | | 第一章 | 总则………………………………………………………………………2 | | --- | --- | | 第二章 | 人员组成…………………………………………………………………2 | | 第三章 | 职责权限………………………………………………………………… 2 | | 第四章 | 决策程序…………………………………………………………………3 | | 第五章 | 议事规则…………………………………………………………………3 | | 第六章 | 附则 …………………………………………………………………… 4 | 第二章 人员组成 第三条 审计委员会成员由三名董事组成,审计委员会成员为不在公司担任 高级管理人员的董事,其中独立董事应当过半数,并由独立董事中会计专业人士 担任召集人。 第四条 审计委员会委员由二分之一以上独立董事或者全体董事的三分之 一提名,由董事会选举产生。 第五条 审计委员会设主 ...
华资实业:包头华资实业股份有限公司《公司章程》(2023年8月修订)
2023-08-29 09:12
公 司 章 程 (修订稿) 2023 年 8 月 | 第一章 总则……………………………………………………………………………………………2 | | --- | | 第二章 经营宗旨和范围………………………………………………………………………………3 | | 第三章 股份……………………………………………………………………………………………3 | | 第一节 股份发行…………………………………………………………………………………3 | | 第二节 股份增减和回购…………………………………………………………………………4 | | 第三节 股份转让…………………………………………………………………………………5 | | 第四章 股东和股东大会………………………………………………………………………………6 | | 第一节 股东………………………………………………………………………………………6 | | 第二节 股东大会的一般规定……………………………………………………………………8 | | 第三节 股东大会的召集………………………………………………………………………10 | | 第四节 股东大会的提案与通知…………… ...
华资实业(600191) - 华资实业关于参加内蒙古辖区上市公司2023年投资者网上集体接待日活动的公告
2023-06-02 08:44
证券代码:600191 证券简称:华资实业 公告编号:临2023-021 包头华资实业股份有限公司 关于参加内蒙古辖区上市公司 2023 年投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 为进一步加强与投资者的互动交流,包头华资实业股份有限公司(以下简称 "公司")将参加由内蒙古证监局、内蒙古上市公司协会与深圳市全景网络有限 公司联合举办的"2023 年内蒙古辖区上市公司投资者集体接待日活动",现将相 关事项公告如下: 本次活动将采用网络远程的方式举行,投资者可登录"全景路演"网站 (https://rs.p5w.net),或关注微信公众号:全景财经,或下载全景路演 APP, 参与本次互动交流,活动时间为 2023 年 6 月 9 日(周五)15:30-17:00。届时公 司副董事长兼总经理刘福安先生、董事会秘书信衍彪先生、财务总监崔美芝女士、 证券事务代表董月源先生将在线就公司 2022 年度业绩、公司治理、发展战略、 经营状况和可持续发展等投资者关心的问题,与投资者进行沟通与交流,欢迎广 ...
华资实业:华资实业关于召开2022年度暨2023年第一季度业绩说明会的公告
2023-05-26 07:36
证券代码:600191 证券简称:华资实业 公告编号:临 2023-020 包头华资实业股份有限公司 关于召开 2022 年度暨 2023 年第一季度 业绩说明会的公告 重要内容提示: 会议召开时间:2023 年 06 月 06 日(星期二) 上午 10:00-11:00 会议召开地点:上海证券交易所上证路演中心(网址: http://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 05 月 30 日(星期二) 至 06 月 05 日(星期 一)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 sar191@foxmail.com 进行提问。公司将在说明会上对 投资者普遍关注的问题进行回答。 包头华资实业股份有限公司(以下简称"公司")已于 2023 年 4 月 28 日发布公司 2022 年度报告及 2023 年第一季度报告,为便于 广大投资者更全面深入地了解公司2022 年度及2023 年第一季度经营 成果、财务状况,公司计划于 2023 年 06 月 06 日 上午 10:00-11:00 举行 2022 年度暨 2 ...
华资实业(600191) - 2023 Q1 - 季度财报
2023-04-27 16:00
Financial Performance - The company's operating revenue for Q1 2023 was CNY 130,428,802.80, representing an increase of 9,643.76 compared to the same period last year[5]. - The net profit attributable to shareholders of the listed company was CNY 44,397,530.60[5]. - The basic earnings per share for the period was CNY 0.0916[6]. - The company achieved operating revenue of RMB 130,428,802.80 in the current period, a significant increase of 9,643.76% compared to RMB 1,338,587.46 in the same period last year, primarily driven by subsidiary Yuwei Biotechnology[16]. - The net profit attributable to shareholders was RMB 44,397,530.60, reversing from a net loss of RMB -34,308,287.63 in the previous year, mainly due to long-term equity investment income and profitability from Yuwei Biotechnology[16]. - Total operating revenue for Q1 2023 reached ¥130,428,802.80, a significant increase from ¥1,338,587.46 in Q1 2022, representing a growth of approximately 9,700%[25]. - Net profit for Q1 2023 was ¥44,397,530.60, a turnaround from a net loss of ¥34,308,287.63 in Q1 2022[26]. - The total comprehensive income for Q1 2023 was ¥52,607,858.29, compared to a loss of ¥36,153,410.63 in Q1 2022[26]. - Basic and diluted earnings per share for Q1 2023 were both ¥0.0916, recovering from a loss of ¥0.0707 per share in Q1 2022[26]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,992,640,272.27, an increase of 3.27% from the end of the previous year[6]. - As of March 31, 2023, total assets amounted to RMB 1,992,640,272.27, compared to RMB 1,929,530,398.05 at the end of 2022, reflecting a growth in total assets[22]. - The total liabilities as of March 31, 2023, were RMB 458,810,719.70, up from RMB 448,308,703.77 at the end of 2022, showing a slight increase in financial obligations[22]. - The company reported a total equity attributable to shareholders of RMB 1,533,829,552.57, an increase from RMB 1,481,221,694.28 at the end of 2022, indicating strengthening shareholder value[22]. Cash Flow - The net cash flow from operating activities was CNY 21,875,626.07, reflecting a significant increase due to sales collections from a subsidiary[5][12]. - The company reported a net cash flow from operating activities of ¥21,875,626.07 in Q1 2023, compared to a negative cash flow of ¥8,888,588.42 in Q1 2022[27]. - The company's cash and cash equivalents increased to RMB 16,110,920.47 from RMB 5,545,126.70 at the end of 2022, indicating improved liquidity[20]. - The company’s cash and cash equivalents at the end of Q1 2023 amounted to ¥16,110,920.47, up from ¥66,275,736.71 at the end of Q1 2022[28]. - Investment activities resulted in a net cash outflow of ¥8,899,634.25 in Q1 2023[28]. Investments and Expenses - The investment income for the period was CNY 37,711,800, an increase of CNY 63,634,400 compared to the same period last year[10][11]. - The company achieved an investment income of ¥37,711,766.23 in Q1 2023, a significant improvement from a loss of ¥25,922,576.28 in Q1 2022[25]. - The company incurred financial expenses of ¥4,038,420.50 in Q1 2023, compared to a financial income of ¥72,260.83 in Q1 2022[25]. Operational Changes - The company experienced a 251.42% increase in contract liabilities, mainly due to advance payments received from customers[9]. - The company has seen a significant increase in sales expenses, up 114.10%, attributed to increased salaries for sales personnel at a subsidiary[9]. - The company is expanding its production capacity through the renovation of production lines, which has impacted cash flow from investing activities negatively[12]. - The company's inventory increased to RMB 191,864,606.09 from RMB 178,759,090.90, indicating a rise in stock levels[20]. - The company's long-term equity investments rose to RMB 984,011,166.24 from RMB 946,855,255.91, reflecting a strategic focus on long-term growth[21]. - The company plans to sell part or all of its shares in Huaxia Bank, holding 61,504,100 shares, which represents 0.39% of the bank's registered capital, to meet future funding needs[17].
华资实业(600191) - 2022 Q4 - 年度财报
2023-04-27 16:00
Financial Performance - The company's operating revenue for 2022 was CNY 368,473,442.30, representing a 772.45% increase compared to CNY 42,234,362.75 in 2021[23] - The net profit attributable to shareholders of the listed company for 2022 was a loss of CNY 165,077,986.80, a decrease of 1,756.25% from a profit of CNY 9,966,999.42 in 2021[23] - The total assets at the end of 2022 were CNY 1,929,530,398.05, an increase of 9.88% from CNY 1,756,043,116.72 at the end of 2021[24] - The net assets attributable to shareholders of the listed company decreased by 11.53% to CNY 1,481,221,694.28 at the end of 2022 from CNY 1,674,252,766.87 at the end of 2021[24] - The cash flow from operating activities for 2022 was a negative CNY 224,747,548.24, compared to a negative CNY 17,713,786.75 in 2021[23] - Basic earnings per share were -0.3404 yuan, a decrease of 1,752.43% compared to the previous year[25] - The weighted average return on equity was -10.46%, a decrease of 11.05 percentage points from the previous year[25] - The net profit attributable to shareholders for 2022 was -165 million yuan, a substantial loss compared to 2021, primarily due to significant losses from the associate company Hengtai Securities, which reported a net profit of -1.29 billion yuan[34] - The investment income from Hengtai Securities was -15.21 million yuan, indicating a negative impact on the company's overall financial performance[34] Subsidiary Performance - The newly established wholly-owned subsidiary, Yuwei Biotechnology, generated operating revenue of 327 million yuan, accounting for 88.80% of the total company revenue[25] - In 2022, the company's total revenue was significantly driven by its subsidiary Yuwei Bio, which generated revenue of 327 million yuan, accounting for 88.80% of the company's total revenue[34] - The subsidiary Yuwei Bio achieved total assets of CNY 402.04 million, net assets of CNY 54.16 million, operating revenue of CNY 327.22 million, and net profit of CNY 19.16 million as of the reporting period[45] Market and Industry Trends - The company faced challenges in sugar production due to raw material supply issues and limited sugar import quotas[33] - The gluten powder industry is shifting towards higher quality and value-added products due to increasing market demand and stricter regulations[36] - The domestic sugar market is expected to maintain stable demand around 14 million tons in 2023, despite fluctuations in international sugar prices[42] - The production of edible alcohol in China reached approximately 662.91 million tons in 2022, reflecting a growth of about 10.40% compared to 2021[38] - The estimated national sugar production for the 2022/23 season is around 10.1 million tons, with a slight increase expected compared to the previous year[42] Operational Challenges - The company is focusing on expanding its grain deep processing business through its subsidiary Yuwei Biotechnology[33] - The company is facing risks related to the seasonal nature of sugar beet production, requiring approximately 500,000 tons of sugar beets for full production capacity[96] - The fluctuation in raw material prices significantly impacts the company's operating performance, with sugar prices experiencing substantial volatility due to domestic and international factors[98] Corporate Governance and Compliance - The company is committed to improving corporate governance and ensuring compliance with relevant laws and regulations, thereby protecting shareholder rights[101] - The board of directors operates independently, ensuring that major decisions are made according to legal procedures and regulatory requirements[101] - The company has implemented measures to enhance the transparency of information disclosure, ensuring all shareholders have equal access to information[103] - The company has established a management system to ensure food safety, but any quality issues could lead to administrative penalties and damage to brand reputation, adversely affecting financial performance[97] Strategic Initiatives - The company plans to enhance its core competitiveness and operational capabilities in 2023, following the expansion into grain deep processing[48] - The company is committed to enhancing operational efficiency and market expansion as part of its strategic transformation[33] - The company aims to expand the market for "Grassland Brand" small packaged sugar and leverage regional advantages in grain deep processing projects[92] - The company is exploring diversified development paths in food production and circulation to create new growth momentum for long-term development[91] Shareholder and Management Changes - The company underwent a change in controlling shareholder, with the new controlling shareholder being Hainan Shengtai Chuangfa Industrial Co., Ltd.[111] - The board of directors and management experienced significant changes due to the change in controlling shareholder, with multiple elections and appointments occurring[115] - Li Yanyong was elected as the chairman of the board following the change in controlling shareholder[115] - Liu Fu'an was appointed as the general manager after the change in controlling shareholder[115] Employee and Training Initiatives - The company has implemented a training program to enhance employee skills and competencies, aligning with strategic development and departmental needs[126] - The total number of employees in the parent company is 391, while the main subsidiaries have 107 employees, resulting in a total of 498 employees[124] - The professional composition includes 230 production personnel, 36 sales personnel, 91 technical personnel, 19 financial personnel, and 122 administrative personnel[124] Environmental and Social Responsibility - The company invested 595,400 CNY in environmental protection during the reporting period[139] - Total donations and public welfare projects amounted to 42,000 CNY, benefiting 26 individuals[140] - The company has established mechanisms for environmental protection[139] Financial Management and Reporting - The company has maintained a complete corporate governance structure, ensuring independent decision-making by its board and management[147] - The audit report confirms that the financial statements of Huazi Industrial as of December 31, 2022, fairly reflect its financial position and operating results[187] - The company has implemented internal controls related to revenue recognition, which were evaluated for effectiveness during the audit[191] - The company has changed its auditing firm to Zhongxinghua Accounting Firm, with an annual audit fee of 800,000 RMB for the 2022 fiscal year[155]
华资实业(600191) - 2022 Q3 - 季度财报
2022-10-28 16:00
2022 年第三季度报告 证券代码:600191 证券简称:华资实业 包头华资实业股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人李延永、主管会计工作负责人崔美芝及会计机构负责人(会计主管人员)霍震宇 保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告 期末比上年 | | --- | --- | --- | --- | --- | | | | | 年初至报告期末 | | | | | 期增减变 | | 同期增减变 | | | | 动幅度(%) | | 动幅度(%) | | 营业收入 | 95,001,210.48 | 163.74 | 134,8 ...
华资实业(600191) - 2022 Q2 - 季度财报
2022-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was CNY 39,897,712.45, a significant increase of 4,110.70% compared to CNY 947,531.29 in the same period last year[16]. - The net profit attributable to shareholders of the listed company was CNY -37,579,994.52, representing a decrease of 3,427.32% from CNY 1,129,436.77 in the previous year[16]. - The net cash flow from operating activities was CNY -211,759,049.81, a substantial decline compared to CNY -11,830,681.98 in the same period last year[16]. - The total assets at the end of the reporting period were CNY 1,873,739,958.81, an increase of 6.70% from CNY 1,756,043,116.72 at the end of the previous year[16]. - The net assets attributable to shareholders of the listed company decreased by 3.49% to CNY 1,615,787,593.91 from CNY 1,674,252,766.87 at the end of the previous year[16]. - The basic earnings per share for the first half of 2022 was CNY -0.0775, a decrease of 3,469.57% compared to CNY 0.0023 in the same period last year[18]. - The weighted average return on net assets was -2.28%, a decrease of 2.35 percentage points from 0.07% in the previous year[18]. - The significant decline in net profit was primarily due to losses reported by Hengtai Securities Co., Ltd., in which the company holds shares[19]. - The increase in operating revenue was mainly attributed to substantial growth in the raw sugar processing and grain trading businesses during the reporting period[19]. Assets and Liabilities - The total assets at the end of the reporting period were 1.87374 billion yuan, with net assets of 1.6157876 billion yuan[29]. - The total current assets as of June 30, 2022, amounted to RMB 311,414,716.53, an increase from RMB 119,794,682.25 at the beginning of the period, reflecting a growth of approximately 160%[82]. - The company's cash and cash equivalents decreased to RMB 52,439,138.33 from RMB 75,164,325.13, representing a decline of about 30.3%[82]. - Total liabilities as of June 30, 2022, were RMB 257,952,364.90, compared to RMB 81,790,349.85 at the beginning of the period, marking an increase of approximately 215%[84]. - The total assets of the company reached RMB 1,873,739,958.81, up from RMB 1,756,043,116.72, reflecting an increase of about 6.7%[84]. - The company's equity attributable to shareholders decreased to RMB 1,615,787,593.91 from RMB 1,674,252,766.87, a decline of approximately 3.5%[84]. Business Operations - The company established a wholly-owned subsidiary, Shandong Yuwei Biotechnology Co., Ltd., focusing on deep processing of grains, producing wheat protein, edible alcohol, and erythritol[30]. - The company plans to strengthen its core competitiveness by focusing on grain deep processing as a breakthrough point while enhancing market management[29]. - The company’s main business includes sugar, flour processing, and grain trading, with sugar being a critical strategic material in the food processing industry[24]. - The company’s flour processing and grain trading businesses are still at a relatively low scale, having started later than its sugar business[26]. - The company is facing significant pressure on sugar imports due to insufficient domestic supply, which is expected to continue[24]. - The establishment of Shandong Yuwei Biotechnology Co., Ltd. is expected to enhance the company's sustainable operational capacity in its main business[30]. Shareholder and Management Changes - The company has undergone a change in controlling shareholder, with Hainan Shengtai Chuangfa Industrial Co., Ltd. becoming the new controlling entity as of May 9, 2022[117]. - The company completed the transfer of 100% equity of Caoyuan Sugar Industry to Hainan Shengtai Chuangfa Industrial Co., Ltd. on May 9, 2022, changing its controlling shareholder[64]. - The total number of shares transferred was 263,455,613, representing 54.32% of the total share capital[70]. - Hainan Shengtai Chuangfa Industrial Co., Ltd. now holds 29.9% of the shares, while Shandong Sitong Investment Co., Ltd. holds 17.61%[74]. - There have been significant changes in the board of directors and management, with multiple new appointments and departures[52]. Financial Management and Cash Flow - The company plans to focus on improving cash flow management and exploring new investment opportunities to enhance financial stability moving forward[102]. - The company's cash flow from operating activities was significantly impacted by increased payments related to operational activities, totaling CNY 240,638,036.90[101]. - The net cash outflow from operating activities was CNY -197,675,585.30, compared to CNY -11,745,619.68 in the first half of 2021, indicating a deterioration in cash flow performance[101]. - Cash inflow from financing activities was CNY 190,000,000.00, with a net cash flow from financing activities of CNY 168,245,477.21 after outflows of CNY 21,754,522.79[102]. Compliance and Governance - The financial statements are prepared based on the assumption of going concern, in accordance with the relevant accounting standards and regulations[120]. - The company confirms that there are no significant doubts regarding the going concern assumption for the next 12 months[121]. - The accounting policies and estimates comply with the requirements of the accounting standards, reflecting the company's financial position and operating results accurately[122]. - The company guarantees the independence of its financial department and accounting system, ensuring no shared bank accounts with related parties[63]. Risks and Challenges - The company faces risks from sugar price fluctuations, which can lead to unstable operating performance due to cyclical supply-demand imbalances in the sugar market[46]. - The company relies on imported raw sugar, and changes in national policies may affect the availability of sufficient raw materials, impacting performance[46]. - The logistics sector is under pressure from the COVID-19 pandemic, leading to decreased market demand while operational costs remain high[46]. - The geopolitical situation between Russia and Ukraine has caused significant price increases in grain commodities, which may adversely affect the company's grain trading and processing operations[47].